Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precure Targeted Accrual and Rapid Growth in Enrollment Trial (TARGET) Study

NCT07756320 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07756320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07756320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precure Targeted Accrual and Rapid Growth in Enrollment Trial (TARGET) Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 7, 2026
Completion date
December 31, 2035
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exposure, environmental, genetic predisposition